UCLA Hematology/Oncology — Los Angeles, California

UCLA Hematology/Oncology is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology has participated in 35 clinical trials with 14 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Advanced Malignancies, NSCLC.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Stemline Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology?

UCLA Hematology/Oncology has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology conducted?

UCLA Hematology/Oncology has 35 clinical trials on record, with 14 currently active. Their work covers HER2-positive Breast Cancer, Advanced Malignancies, NSCLC.

Is UCLA Hematology/Oncology accredited by Crixeo Health?

Yes — UCLA Hematology/Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UCLA Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.